Using [beta]-decay to map the E2 strength in the Cd isotopes and the downfall of vibrational motion

Publisher's Version/PDFThe &beta; decay of 112Ag has been used to populate spin 0+ and 2+ states in 112Cd to 3 MeV excitation energy. The statistical quality obtained allows the extraction of very weak &gamma;-ray branching ratios that, combined with known level lifetimes, enables the determination of the B(E2) values or upper limits for transitions populating the proposed two-phonon states. While candidates for 3+, 4+, and 6+ three-phonon levels have been identified, there are no candidates for the 0+ and 2+&nbsp;three phonon levels, and the upper limits of the B(E2) values indicate that phonon E2 strength is not fragmented, but absent below 5ℏw2.</sub

DESCANT and β-Delayed Neutron Measurements at TRIUMF

The DESCANT array (Deuterated Scintillator Array for Neutron Tagging) consists of up to 70 detectors, each filled with approximately 2 liters of deuterated benzene. This scintillator material o_ers pulse-shape discrimination (PSD) capabilities to distinguish between neutrons and γ-rays interacting with the scintillator material. In addition, the anisotropic nature of n – d scattering allows for the determination of the neutron energy spectrum directly from the pulse height spectrum, complementing the traditional time-of-flight (ToF) information. DESCANT can be coupled either to the TIGRESS (TRIUMF-ISAC Gamma-Ray Escape Suppressed Spectrometer) γ-ray spectrometer [1] located in the ISAC-II [2] hall of TRIUMF for in-beam experiments, or to the GRIFFIN (Gamma-Ray Infrastructure For Fundamental Investigations of Nuclei) γ-ray spectrometer [3] located in the ISAC-I hall of TRIUMF for decay spectroscopy experiments

Probing the low-lying level structure of 94Zr through β¯ decay

223-227Low-lying states of 94Zr are populated following b- decay of 94Y, and the emitted g rays from 94Zr are detected using the 8p spectrometer composed of 20 Compton-suppressed HPGe detectors. High- statistics coincidence data have been used for the placement of very weak decay branches in the level scheme. Combining the results of level lifetimes from a previous experiment and the precisely measured branching ratio values of the weak decay branches from the present experiment, it is possible to extract the B(E2) values for all the possible decay branches from a given level. These values are helpful for proper identification of the collective and non-collective states of 94Zr. The experimental findings have been compared with predictions from shell-model calculations with a limited valence space; however, these calculations are inadequate in reproducing all of the measured spectroscopic quantities

Far from \u27Easy\u27 Spectroscopy with the 8π and GRIFFIN Spectrometers at TRIUMF-ISAC

The 8π spectrometer, installed at the TRIUMF-ISAC facility, was the world\u27s most sensitive γ-ray spectrometer dedicated to β-decay studies. A description is given of the 8π spectrometer and its auxiliary detectors including the plastic scintillator array SCEPTAR used for β-particle tagging and the Si(Li) array PACES for conversion electron measurements, its moving tape collector, and its data acquisition system. The recent investigation of the decay of 124Cs to study the nuclear structure of 124Xe, and how the β-decay measurements complemented previous Coulomb excitation studies, is highlighted, including the extraction of the deformation parameters for the excited 0+ bands in 124Xe. As a by-product, the decay scheme of the (7+) 124Cs isomeric state, for which the data from the PACES detectors were vital, was studied. Finally, a description of the new GRIFFIN spectrometer, which uses the same auxiliary detectors as the 8π spectrometer, is given

Gamma-ray spectroscopy at TRIUMF-ISAC: The new frontier of radioactive ion beam research

High-resolution gamma-ray spectroscopy is essential to fully exploit the unique scientific opportunities at the next generation radioactive ion beam facilities such as the TRTUMF Isotope Separator and Accelerator (TSAC). At IS AC the 871 spectrometer and its associated auxiliary detectors is optimize for p-decay studies while TIGRESS an array of segmented clover HPGe detectors has been designed for studies with accelerated beams. This paper gives a brief overview of these facilities and also presents recent examples of the diverse experimental program carried out at the STI spectrometer. © 2009 American Institute of Physics

High-precision half-life and branching-ratio measurements for superallowed Fermi β \u3csup\u3e+\u3c/sup\u3e emitters at TRIUMF - ISAC

A program of high-precision half-life and branching-ratio measurements for superallowed Fermi β emitters is being carried out at TRIUMF\u27s Isotope Separator and Accelerator (ISAC) radioactive ion beam facility. Recent half-life measurements for the superallowed decays of 14O, 18Ne, and 26Alm, as well as branching-ratio measurements for 26Alm and 74Rb are reported. These results provide demanding tests of the Standard Model and the theoretical isospin symmetry breaking (ISB) corrections in superallowed Fermi β decays. © Owned by the authors, published by EDP Sciences, 2014

The TRIUMF nuclear structure program and TIGRESS

The isotope separator and accelerator (ISAC) facility located at the TRIUMF laboratory in Vancouver, Canada, is one of the world\u27s most advanced isotope separator on-line-type radioactive ion beam facilities. An extensive γ-ray spectroscopy programme at ISAC is centred around two major research facilities: (i) the 8π γ-ray spectrometer for β-delayed γ-ray spectroscopy experiments with the low-energy beams from ISAC-I, and (ii) the next generation TRIUMF-ISAC gamma-ray escape suppressed spectrometer (TIGRESS) for in-beam experiments with the accelerated radioactive-ion beams. An overview of these facilities and recent results from the diverse programme of nuclear structure and fundamental interaction studies they support is presented. © 2007 Elsevier B.V. All rights reserved

Ground-State and Pairing-Vibrational Bands with Equal Quadrupole Collectivity in \u3csup\u3e124\u3c/sup\u3eXe

The nuclear structure of 124Xe has been investigated via measurements of the β+/EC decay of 124Cs with the 8πγ-ray spectrometer at the TRIUMF-ISAC facility. . . . For the remainder of this abstract, please visit: http://dx.doi.org/10.1103/PhysRevC.91.04432

Conversion electrons from high-statistics β-decay measurements with the 8π spectrometer at TRIUMF-ISAC

The 8π spectrometer, located at TRIUMF-ISAC, was the world\u27s most powerful spectrometer dedicated to β-decay studies until its decommissioning in early 2014 for replacement with the GRIFFIN array. An integral part of the 8π spectrometer was the Pentagonal Array for Conversion Electron Spectroscopy (PACES) consisting of 5 Si(Li) detectors used for charged-particle detection. PACES enabled both γ - e- and e- - e- coincidence measurements, which were crucial for increasing the sensitivity for discrete e- lines in the presence of large backgrounds. Examples from a 124Cs decay experiment, where the data were vital for the expansion of the 124Csm decay scheme, are shown. With sufficient statistics, measurements of conversion coefficients can be used to extract the E0 components of Jπ → Jπ transitions for J ≠ 0, which is demonstrated for data obtained in 110In→110Cd decay. With knowledge of the shapes of the states involved, as obtained, for example, from the use of Kumar-Cline shape invariants, the mixing of the states can be extracted

Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)

Purpose The CIGMA study investigated a novel human polyclonal antibody preparation (trimodulin) containing ~ 23% immunoglobulin (Ig) M, ~ 21% IgA, and ~ 56% IgG as add-on therapy for patients with severe community-acquired pneumonia (sCAP). Methods In this double-blind, phase II study (NCT01420744), 160 patients with sCAP requiring invasive mechanical ventilation were randomized (1:1) to trimodulin (42 mg IgM/kg/day) or placebo for five consecutive days. Primary endpoint was ventilator-free days (VFDs). Secondary endpoints included 28-day all-cause and pneumonia-related mortality. Safety and tolerability were monitored. Exploratory post hoc analyses were performed in subsets stratified by baseline C-reactive protein (CRP; ≥ 70 mg/L) and/or IgM (≤ 0.8 g/L). Results Overall, there was no statistically significant difference in VFDs between trimodulin (mean 11.0, median 11 [n = 81]) and placebo (mean 9.6; median 8 [n = 79]; p = 0.173). Twenty-eight-day all-cause mortality was 22.2% vs. 27.8%, respectively (p = 0.465). Time to discharge from intensive care unit and mean duration of hospitalization were comparable between groups. Adverse-event incidences were comparable. Post hoc subset analyses, which included the majority of patients (58–78%), showed significant reductions in all-cause mortality (trimodulin vs. placebo) in patients with high CRP, low IgM, and high CRP/low IgM at baseline. Conclusions No significant differences were found in VFDs and mortality between trimodulin and placebo groups. Post hoc analyses supported improved outcome regarding mortality with trimodulin in subsets of patients with elevated CRP, reduced IgM, or both. These findings warrant further investigation